32
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Epidemiological Characterisation of Chronic Diseases Among Civil Servants in Hebei Province, China: A Cross-Sectional Real-World Study of Approximately 50,000 Adults

, , , &
Pages 1301-1313 | Received 08 Feb 2024, Accepted 05 May 2024, Published online: 18 May 2024

References

  • Maguolo A, Gabbianelli R, Maffeis C. Micronutrients in early life and offspring metabolic health programming: a promising target for preventing non-communicable diseases. Eur J Clin Nutr. 2023. doi:10.1038/s41430-023-01333-4
  • Peña-Jorquera H, Cid-Jofré V, Landaeta-Díaz L, et al. Plant-based nutrition: exploring health benefits for atherosclerosis, chronic diseases, and metabolic syndrome-A comprehensive review. Nutrients. 2023;15(14):3244. doi:10.3390/nu15143244
  • Stewart S, Patel SK, Lancefield TF, et al. Vulnerability to environmental and climatic health provocations among women and men hospitalised with chronic heart disease: insights from the RESILIENCE TRIAL cohort. Eur J Cardiovasc Nurs. 2023:zvad076. doi:10.1093/eurjcn/zvad076
  • Pan X, Jia Z, Zhen R, et al. Mechanisms of small intestine involvement in obesity-induced atherosclerosis. Diabetes Metab Syndr Obes. 2023;16:1941–1952. doi:10.2147/DMSO.S421650
  • Chen W, Ma Y, Yu C. Unmet chronic care needs and insufficient nurse staffing to achieve universal health coverage in China: analysis of the Global Burden of Disease Study 2019. Int J Nurs Stud. 2023;144:104520. doi:10.1016/j.ijnurstu.2023.104520
  • Serván-Mori E, Orozco-Núñez E, Guerrero-López CM, et al. A gender-based and quasi-experimental study of the catastrophic and impoverishing health-care expenditures in Mexican households with elderly members, 2000–2020. Health Syst Reform. 2023;9(1):2183552. doi:10.1080/23288604.2023.2183552
  • Almalki ZS, Alahmari AK, Alqahtani N, et al. Households’ direct economic burden associated with chronic non-communicable diseases in Saudi Arabia. Int J Environ Res Public Health. 2022;19(15):9736. doi:10.3390/ijerph19159736
  • Fortini MB, Erickson TA, Leining LM, et al. Review of toxocariasis at a children’s hospital prompting need for public health interventions. Pediatr Infect Dis J. 2023;42(10):862–866. doi:10.1097/INF.0000000000004042
  • Kankaanpää SL, Lehti V, Solin P, Salama E. Fostering trust and understanding in social and healthcare services with migrant-origin parents: qualitative focus-group interviews of foreign-born mothers living in Finland. Eur Child Adolesc Psychiatry. 2023. doi:10.1007/s00787-023-02288-4
  • Mathews N, Alodan K, Kuehne N, et al. Prevalence and risk factors for moral distress in pediatric oncology health care professionals. JCO Oncol Pract. 2023:OP2300059. doi:10.1200/OP.23.00059
  • Pan X, Chen X, Ren L, Li Z, Chen S. Correlation of obesity and overweight with cervical vascular function among healthy populations. Diabetes Metab Syndr Obes. 2022;15:2927–2938. doi:10.2147/DMSO.S383880
  • Pan X, Yue L, Ban J, Ren L, Chen S. Effects of semaglutide on cardiac protein expression and cardiac function of obese mice. J Inflamm Res. 2022;15:6409–6425. doi:10.2147/JIR.S391859
  • Wang L, Zhou B, Zhao Z, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18. Lancet. 2021;398(10294):53–63. doi:10.1016/S0140-6736(21)00798-4
  • Chen K, Shen Z, Gu W, et al. Prevalence of obesity and associated complications in China: a cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab. 2023;25(11):3390–3399. doi:10.1111/dom.15238
  • NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396. doi:10.1016/S0140-6736(16)30054-X
  • Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology. 2011;16(8):1165–1172. doi:10.1111/j.1440-1843.2011.02062.x
  • Fang YH, He YN, Bai GY, Zhao WH. 2012年中国20~79岁男性饮酒现状分析 [Prevalence of alcohol drinking in males aged 20–79 years in China, 2012]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(3):280–285. Chinese. doi:10.3760/cma.j.issn.0254-6450.2018.03.006
  • Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the china hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
  • Yin R, Yin L, Li L, et al. Hypertension in China: burdens, guidelines and policy responses: a state-of-The-art review. J Hum Hypertens. 2022;36(2):126–134. doi:10.1038/s41371-021-00570-z
  • Pan J, Ren Z, Li W, et al. Prevalence of hyperlipidemia in Shanxi Province, China and application of Bayesian networks to analyse its related factors. Sci Rep. 2018;8(1):3750. doi:10.1038/s41598-018-22167-2
  • Zhang M, Zhu X, Wu J, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19. Front Immunol. 2022;12:791983. doi:10.3389/fimmu.2021.791983
  • Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–2506. doi:10.1001/jama.2021.22208
  • Zeng Y, Li FF, Yuan SQ, et al. Prevalence of hyperhomocysteinemia in china: an updated meta-analysis. Biology. 2021;10(10):959. doi:10.3390/biology10100959
  • Qin YY, Wang P, Qin JQ, et al. Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors. J Clin Lab Anal. 2018;32(1):e22178. doi:10.1002/jcla.22178
  • Yang Y, Zeng Y, Yuan S, et al. Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China. BMJ Open. 2021;11(12):e048575. doi:10.1136/bmjopen-2020-048575
  • Zhou J, Zhou F, Wang W, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71(5):1851–1864. doi:10.1002/hep.31150
  • Xu WP, Wang XH, Wu SP, et al. The prevalence and associated factors of simple hepatic cysts in Shanghai: a population-based cross-sectional study. Chin Med J. 2021;134(10):1248–1250. doi:10.1097/CM9.0000000000001361
  • Wu Q, Ju C, Deng M, Liu X, Jin Z. Prevalence, risk factors and clinical characteristics of renal dysfunction in Chinese outpatients with growth simple renal cysts. Int Urol Nephrol. 2022;54(7):1733–1740. doi:10.1007/s11255-021-03065-5
  • Lv F, Wang G, Ding D, et al. Epidemiological survey to determine the prevalence of cholecystolithiasis in Uyghur, Kazakh, and Han Ethnic Groups in the Xinjiang Uyghur Autonomous Region of China: cross-sectional studies. BMC Gastroenterol. 2021;21(1):125. doi:10.1186/s12876-021-01677-w
  • Su Z, Gong Y, Liang Z. Prevalence of gallstone in Mainland China: a meta-analysis of cross-sectional studies. Clin Res Hepatol Gastroenterol. 2020;44(4):e69–e71. doi:10.1016/j.clinre.2020.04.015
  • Zeng Q, He Y, Qiang DC, Wu LX. Prevalence and epidemiological pattern of gallstones in urban residents in China. Eur J Gastroenterol Hepatol. 2012;24(12):1459–1460. doi:10.1097/MEG.0b013e3283583d13
  • Wang W, Fan J, Huang G, et al. Prevalence of kidney stones in mainland China: a systematic review. Sci Rep. 2017;7:41630. doi:10.1038/srep41630
  • Yamin Z, Xuesong B, Zhen Z, Yue H, Liwei L, Fei L. Correlation of dyslipidemias and gallbladder polyps-A large retrospective study among Chinese population. Asian J Surg. 2020;43(1):181–185. doi:10.1016/j.asjsur.2019.01.013
  • Zhang X, Guan L, Tian H, Li Y. Prevalence and risk factors of gallbladder stones and polyps in Liaoning, China. Front Med Lausanne. 2022;9:865458. doi:10.3389/fmed.2022.865458
  • Song P, Xia W, Zhu Y, et al. Prevalence of carotid atherosclerosis and carotid plaque in Chinese adults: a systematic review and meta-regression analysis. Atherosclerosis. 2018;276:67–73. doi:10.1016/j.atherosclerosis.2018.07.020
  • Song P, Fang Z, Wang H, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721–e729. doi:10.1016/S2214-109X(20)30117-0
  • Liang X, Kong Y, Shang H, et al. Computed tomography findings, associated factors, and management of pulmonary nodules in 54,326 healthy individuals. J Cancer Res Ther. 2022;18(7):2041–2048. doi:10.4103/jcrt.jcrt_1586_22
  • He YT, Zhang YC, Shi GF, et al. Risk factors for pulmonary nodules in north China: a prospective cohort study. Lung Cancer. 2018;120:122–129. doi:10.1016/j.lungcan.2018.03.021
  • Wang W, Guo Y, Zhang D, Tian Y, Zhang X. The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys. Sci Rep. 2015;5:13546. doi:10.1038/srep13546
  • Huang X, Qiu Y, Bao F, et al. Artificial intelligence breast ultrasound and handheld ultrasound in the BI-RADS categorization of breast lesions: a pilot head to head comparison study in screening program. Front Public Health. 2023;10:1098639. doi:10.3389/fpubh.2022.1098639
  • Li Y, Jin C, Li J, et al. Prevalence of thyroid nodules in China: a health examination cohort-based study. Front Endocrinol. 2021;12:676144. doi:10.3389/fendo.2021.676144
  • Pan X, Chen X, Ren L, Li Z, Chen S, Wan C. Correlation between cardiac ultrasound index and cardiovascular risk in healthy obese and overweight populations. Int J Clin Pract. 2022;2022:2235994. doi:10.1155/2022/2235994